Before the Next Nvidia-Style Run, Here Are 3 AI Stocks Worth Watching

    Key Points Astera Labs is capitalizing on the growing networking opportunities inside next-generation AI infrastructure. Marvell is playing a crucial role in enabling hyperscalers to deploy custom chips and fast optical networking capabilities. Credo is targeting the fast-growing AI connectivity opportunity. 10 stocks we like better than Astera Labs › Nvidia (NASDAQ: NVDA) has been…

    Read More

      Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?

      Key Points Artificial intelligence (AI) is slowly reshaping how industries, including healthcare, operate. Various companies are looking to implement AI tools in the sector to boost efficiency and productivity while cutting costs. Recursion Pharmaceuticals (NASDAQ: RXRX) is doing so specifically within the biotech niche, but the company’s efforts haven’t been rewarded by the market, at…

      Read More

        Why Did Nvidia Raise Its Dividend by 2,400%?

        Key Points Investors historically reaped gains from Nvidia primarily through share price appreciation. The company’s decision to raise its dividend could be a sign that it wants to welcome a new cohort of investors beyond those seeking artificial intelligence (AI)-driven growth. Nvidia’s dividend is now at a level that should appeal to value funds, endowments,…

        Read More